Bio-Techne Corp (NASDAQ: TECH) has reported E.P.S. of $0.31 for its third fiscal quarter (ending March 31) versus $0.45 for the same period a year ago — a decline of -31%. Relative to the consensus estimate of $0.54, this was a shortfall of $-0.23. For the latest four quarters through March 31, E.P.S. were $1.29 compared to $1.73 a year ago — a decline of -26%.
Recent Price Action
Bio-Techne Corp (NASDAQ: TECH) stock enjoyed a major increase of 16.2% on 5/1/24. The shares closed at $73.46. Moreover, exceptionally high trading volume at 284% of normal accompanied the advance. Relative to the market the stock has been weak over the last nine months but has risen 15.3% during the last week.
Current PriceTarget Research Rating
Reflecting future returns on capital that are forecasted to exceed the cost of capital, TECH is expected to continue to be an important Value Builder.
Bio-Techne has a current Value Trend Rating of F (Lowest Rating). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing highly consistent signals. Bio-Techne has a poor Power Rating of 30 and a poor Appreciation Score of 24, with the Lowest Value Trend Rating the result.
Rating Review
In light of this new information and very positive price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment